Targeting of NH(2)-terminal–processed Microsomal Protein to Mitochondria: A Novel Pathway for the Biogenesis of Hepatic Mitochondrial P450MT2

Por Addya, Sankar, Anandatheerthavarada, Hindupur K., Biswas, Gopa, Bhagwat, Shripad V., Mullick, Jayati, Avadhani, Narayan G.
Publicado em 1997

CD13/APN is activated by angiogenic signals and is essential for capillary tube formation

Por Bhagwat, Shripad V., Lahdenranta, Johanna, Giordano, Ricardo J., Arap, Wadih, Pasqualini, Renata, Shapiro, Linda H.
Publicado no Blood (2001)

Accumulation of Mitochondrial P450MT2, NH(2)-terminal Truncated Cytochrome P4501A1 in Rat Brain during Chronic Treatment with β-Naphthoflavone: A ROLE IN THE METABOLISM OF NEUROACT...

Por Boopathi, Ettickan, Anandatheerthavarada, Hindupur K., Bhagwat, Shripad V., Biswas, Gopa, Fang, Ji-Kang, Avadhani, Narayan G.
Publicado em 2000

Evaluation of ERK as a therapeutic target in acute myelogenous leukemia A novel ERK inhibitor for AML

Por Weisberg, Ellen, Meng, Chengcheng, Case, Abigail, Sattler, Martin, Tiv, Hong L., Gokhale, Prafulla C., Buhrlage, Sara, Wang, Jinhua, Gray, Nathanael, Stone, Richard, Liu, Suiyang, Bhagwat, Shripad V., Tiu, Ramon V., Adamia, Sophia, Griffin, James D.
Publicado no Leukemia (2019)

Identification of Druggable Cancer Driver Genes Amplified across TCGA Datasets

Por Chen, Ying, McGee, Jeremy, Chen, Xianming, Doman, Thompson N., Gong, Xueqian, Zhang, Youyan, Hamm, Nicole, Ma, Xiwen, Higgs, Richard E., Bhagwat, Shripad V., Buchanan, Sean, Peng, Sheng-Bin, Staschke, Kirk A., Yadav, Vipin, Yue, Yong, Kouros-Mehr, Hosein
Publicado em 2014

Molecular dissection of CRC primary tumors and their matched liver metastases reveals critical role of immune microenvironment, EMT and angiogenesis in cancer metastasis

Por Liu, Jiangang, Cho, Yong Beom, Hong, Hye Kyung, Wu, Song, Ebert, Philip J., Bray, Steven M., Wong, Swee Seong, Ting, Jason C., Calley, John N., Whittington, Catherine F., Bhagwat, Shripad V., Reinhard, Christoph, Wild, Robert, Nam, Do-Hyun, Aggarwal, Amit, Lee, Woo Yong, Peng, Sheng-Bin
Publicado no Sci Rep (2020)

ERK inhibitor LY3214996-based treatment strategies for RAS-driven lung cancer

Por Köhler, Jens, Zhao, Yutong, Li, Jiaqi, Gokhale, Prafulla C., Tiv, Hong L., Knott, Aine R., Wilkens, Margaret K., Soroko, Kara M., Lin, Mika, Ambrogio, Chiara, Musteanu, Monica, Ogino, Atsuko, Choi, Jihyun, Bahcall, Magda, Bertram, Arrien A., Chambers, Emily S., Paweletz, Cloud P., Bhagwat, Shripad V., Manro, Jason R., Tiu, Ramon V., Jänne, Pasi A.
Publicado no Mol Cancer Ther (2021)

Low-Dose Vertical Inhibition of the RAF-MEK-ERK Cascade Causes Apoptotic Death of KRAS Mutant Cancers

Por Ozkan-Dagliyan, Irem, Diehl, J. Nathaniel, George, Samuel D., Schaefer, Antje, Papke, Bjoern, Klotz-Noack, Kathleen, Waters, Andrew M., Goodwin, Craig M., Gautam, Prson, Pierobon, Mariaelena, Peng, Sen, Gilbert, Thomas S.K., Lin, Kevin H., Dagliyan, Onur, Wennerberg, Krister, Petricoin, Emanuel F., Tran, Nhan L., Bhagwat, Shripad V., Tiu, Ramon V., Peng, Sheng-Bin, Herring, Laura E., Graves, Lee M., Sers, Christine, Wood, Kris C., Cox, Adrienne D., Der, Channing J.
Publicado no Cell Rep (2020)